(Q34513178)

2 August 2017

1 reference

title

Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype (English)

1 reference

autoimmune lymphoproliferative syndrome

2 August 2017

0 references

1 reference

Adrian J Thrasher

2

0 references

Austen Worth

series ordinal

1

object named as

Austen Worth

1 reference

2 August 2017

H Bobby Gaspar

3

1 reference

PubMed ID

16611303

2 August 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

British Journal of Haematology

2 August 2017

1 reference

2 August 2017

133

1 reference

2 August 2017

124-140

1 reference

2 August 2017

2

1 reference

Molecular ordering of the initial signaling events of CD95.

2 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Germline FAS gene mutation in a case of ALPS and NLP Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

FAS gene mutation in a case of autoimmune lymphoproliferative syndrome type IA with accumulation of gammadelta+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Caspases: an ancient cellular sword of Damocles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Description of serologic features in autoimmune lymphoproliferative syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Caspases: the executioners of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

A co-evolution perspective of the TNFSF and TNFRSF families in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

The autoimmune lymphoproliferative syndrome (Canale-Smith) in adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Role of inherited defects decreasing Fas function in autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Report of a factor VIII inhibitor in a patient with autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

The death effector domains (DEDs) of the molluscum contagiosum virus MC159 v-FLIP protein are not functionally interchangeable with each other or with the DEDs of caspase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Anti-platelet antibodies associated with the Canale-Smith syndrome bind to the same platelet glycoprotein complexes as those of idiopathic thrombocytopenic purpura patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Faces and phases of human CD8 T-cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

The genetics of cell death: approaches, insights and opportunities in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Autoimmune lymphoproliferative syndrome with somatic Fas mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Worms, life, and death (Nobel lecture).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Assignment of the human Fas antigen gene (Fas) to 10q24.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Clinical, immunological, and pathological consequences of Fas-deficient conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

The relevance of NF-kappaB for CD95 signaling in tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Identification of SNF1/AMP kinase-related kinase as an NF-kappaB-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Pathological findings in human autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

NF-kappaB in cancer: a marked target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

The TNF and TNF receptor superfamilies: integrating mammalian biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Autoimmune lymphoproliferative syndrome: report of two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

The CD95(APO-1/Fas) DISC and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Cell-death signaling and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

From antigen to activation: specific signal transduction pathways linking antigen receptors to NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Caspases: intracellular signaling by proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Caspase activation: the induced-proximity model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Corpse clearance defines the meaning of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Mechanisms of caspase activation and inhibition during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

SPOTS: signaling protein oligomeric transduction structures are early mediators of death receptor-induced apoptosis at the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Identification of amino acid residues important for ligand binding to Fas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

T-lymphocyte death during shutdown of an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

RBC autoantibodies in autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

A novel domain within the 55 kd TNF receptor signals cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

21 January 2018

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Caspase-10 is an initiator caspase in death receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

The use of the anti-malaria drug Fansidar (pyrimethamine and sulphadoxine) in the treatment of a patient with autoimmune lymphoproliferative syndrome and Fas deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Reversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Childhood linear IgA disease in association with autoimmune lymphoproliferative syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Viral FLIP impairs survival of activated T cells and generation of CD8+ T cell memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Prominent dominant negative effect of a mutant Fas molecule lacking death domain on cell-mediated induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Induction of apoptosis in mature T cells by tumour necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Increased spontaneous in vitro apoptosis in double negative T cells of humans with a fas/apo-1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05993.X

10.1111/J.1365-2141.2006.05993.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

16611303